Mizuho Initiates Coverage On Palvella Therapeutics with Outperform Rating, Announces Price Target of $205
Benzinga Newsdesk 10 months ago
NewsPrice TargetInitiationAnalyst Ratings
Mizuho analyst Graig Suvannavejh initiates coverage on Palvella Therapeutics (NASDAQ:PVLA) with a Outperform rating and announces Price Target of $205.
Mizuho analyst Graig Suvannavejh initiates coverage on Palvella Therapeutics (NASDAQ:PVLA) with a Outperform rating and announces Price Target of $205.